Acutaas Chemicals Limited (BOM:543349)

Market Cap	208.36B +106.7%
Revenue (ttm)	12.15B +31.6%
Net Income	2.87B +136.4%
EPS	34.76 +159.1%
Shares Out	n/a
PE Ratio	72.61
Forward PE	57.02
Dividend	1.50 (0.06%)
Ex-Dividend Date	Sep 18, 2025

Volume	26,456
Average Volume	22,147
Open	2,534.05
Previous Close	2,525.30
Day's Range	2,474.50 - 2,561.85
52-Week Range	930.03 - 2,580.00
Beta	n/a
RSI	67.06
Earnings Date	May 30, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 879
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In fiscal year 2025, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.